Bank of America
PRME icon

Bank of America’s Prime Medicine PRME Stock Holding History

Bank of America’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.62M Buy
981,335
+404,331
+70% +$1.34M ﹤0.01% 3801
2026
Q1 		$2.01M Sell
577,004
-71,008
-11% -$270K ﹤0.01% 4118
2025
Q4 		$2.25M Buy
648,012
+537,170
+485% +$2.39M ﹤0.01% 3974
2025
Q3 		$614K Sell
110,842
-33,669
-23% -$137K ﹤0.01% 5654
2025
Q2 		$357K Buy
144,511
+31,585
+28% +$48.7K ﹤0.01% 5888
2025
Q1 		$225K Sell
112,926
-317,687
-74% -$810K ﹤0.01% 6109
2024
Q4 		$1.26M Sell
430,613
-54,512
-11% -$191K ﹤0.01% 4832
2024
Q3 		$1.88M Buy
485,125
+57,729
+14% +$267K ﹤0.01% 4609
2024
Q2 		$2.2M Buy
427,396
+5,976
+1% +$36.2K ﹤0.01% 4375
2024
Q1 		$2.95M Sell
421,420
-49,176
-10% -$373K ﹤0.01% 4119
2023
Q4 		$4.17M Buy
470,596
+167,954
+55% +$1.29M ﹤0.01% 3701
2023
Q3 		$2.89M Buy
302,642
+155,127
+105% +$2.01M ﹤0.01% 3915
2023
Q2 		$2.16M Sell
147,515
-2,752
-2% -$38.4K ﹤0.01% 4162
2023
Q1 		$1.85M Buy
150,267
+102,908
+217% +$1.68M ﹤0.01% 4414
2022
Q4 		$880K Buy
+47,359
New +$855K ﹤0.01% 4950

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Bank of America's PRME Position: Q2 2026 in Review

Bank of America increased its Prime Medicine (PRME) stake by 70% in Q2 2026, buying an estimated $1.34M and bringing the position to 981,335 shares worth $3.62M. The position accounts for ﹤0.01% of the portfolio, ranked #3801.

Bank of America first reported a position in PRME in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.17M in Q4 2023. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Bank of America held 981,335 shares of Prime Medicine worth $3.62M as of Q2 2026.
  • Bank of America bought 404,331 Prime Medicine shares in Q2 2026, an estimated $1.34M.
  • Prime Medicine made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #3801 holding.
  • Bank of America first reported a position in Prime Medicine in Q4 2022 and has held it in 15 quarters since.
  • Bank of America's Prime Medicine position peaked at $4.17M in Q4 2023.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.